These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31493853)

  • 21. Childhood Cushing's syndrome induced by betamethasone nose drops, and repeat prescriptions.
    Findlay CA; Macdonald JF; Wallace AM; Geddes N; Donaldson MD
    BMJ; 1998 Sep; 317(7160):739-40. PubMed ID: 9732346
    [No Abstract]   [Full Text] [Related]  

  • 22. Cushing's syndrome due to interaction between ritonavir or cobicistat and corticosteroids: a case-control study in the French Pharmacovigilance Database.
    Peyro-Saint-Paul L; Besnier P; Demessine L; Biour M; Hillaire-Buys D; de Canecaude C; Fedrizzi S; Parienti JJ
    J Antimicrob Chemother; 2019 Nov; 74(11):3291-3294. PubMed ID: 31369085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case of growth retardation and cushing's syndrome due to excessive application of betamethasone-17-valerate ointment.
    Vermeer BJ; Heremans GF
    Dermatologica; 1974; 149(5):299-304. PubMed ID: 4618210
    [No Abstract]   [Full Text] [Related]  

  • 24. Betamethasone cream to treat diapers rash causing Cushing syndrome.
    Ali T; Habib A; Zohair M; Aman L
    J Pediatr Endocrinol Metab; 2023 Apr; 36(4):414-417. PubMed ID: 36788666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iatrogenic Cushing's syndrome.
    Kelly A; Nelson K; Goodwin M; McCluggage J
    Br Med J; 1972 Oct; 4(5832):114. PubMed ID: 5077452
    [No Abstract]   [Full Text] [Related]  

  • 26. Iatrogenic Cushing's syndrome.
    Ganguly S; Dutta S; Chakraborty S; Ghosh J
    Indian Pediatr; 1998 Dec; 35(12):1236-7. PubMed ID: 10216705
    [No Abstract]   [Full Text] [Related]  

  • 27. Iatrogenic Cushing's syndrome: a different story.
    Agadi S
    Lancet; 2003 Mar; 361(9362):1059. PubMed ID: 12660089
    [No Abstract]   [Full Text] [Related]  

  • 28. Potential hazards of topical steroid therapy.
    Stoppoloni G; Prisco F; Santinelli R; Sicuranza G; Giordano C
    Am J Dis Child; 1983 Nov; 137(11):1130-1. PubMed ID: 6637925
    [No Abstract]   [Full Text] [Related]  

  • 29. Potent topical steroids and psoriasis.
    Sandoval Cruz M; Moncada B
    J Am Acad Dermatol; 1988 Feb; 18(2 Pt 1):387. PubMed ID: 3346427
    [No Abstract]   [Full Text] [Related]  

  • 30. Rezolsta® (Darunavir/Cobicistat): First Boosted Protease Inhibitor Co-formulated with Cobicistat.
    Curran A; Pérez-Valero I; Moltó J
    AIDS Rev; 2015; 17(2):114-20. PubMed ID: 26035169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Case Of Iatrogenic Cushing's Syndrome By Topical Triamcinolone.
    Zil-E-Ali A; Janjua OH; Latif A; Aadil M
    J Ayub Med Coll Abbottabad; 2018; 30(1):121-123. PubMed ID: 29504347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of Darunavir-Cobicistat as a Treatment Option for Critically Ill Patients with SARS-CoV-2 Infection.
    Kim EJ; Choi SH; Park JS; Kwon YS; Lee J; Kim Y; Lee SY; Choi EY
    Yonsei Med J; 2020 Sep; 61(9):826-830. PubMed ID: 32882767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cushing's syndrome: hidden risk in usage of topical corticosteroids.
    Buluş AD; Andıran N; Koçak M
    J Pediatr Endocrinol Metab; 2014 Sep; 27(9-10):977-81. PubMed ID: 24854522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of Cushing's syndrome after use of a herbal remedy.
    Krapf R
    Lancet; 2002 Dec; 360(9348):1884. PubMed ID: 12480390
    [No Abstract]   [Full Text] [Related]  

  • 35. Darunavir/cobicistat once daily for the treatment of HIV.
    Kakuda TN; Crauwels H; Opsomer M; Tomaka F; van de Casteele T; Vanveggel S; Iterbeke K; de Smedt G
    Expert Rev Anti Infect Ther; 2015 Jun; 13(6):691-704. PubMed ID: 25962100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cushing's Syndrome in a 6-month-old Boy: A Rare Side-effect due to Inadequate use of Topical Corticosteroids.
    Ciccone S; Marini R; Bizzarri C; El Hachem M; Cappa M
    Acta Derm Venereol; 2016 Jan; 96(1):138-9. PubMed ID: 26038976
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacokinetics of dolutegravir with and without darunavir/cobicistat in healthy volunteers.
    Elliot ER; Cerrone M; Challenger E; Else L; Amara A; Bisdomini E; Khoo S; Owen A; Boffito M
    J Antimicrob Chemother; 2019 Jan; 74(1):149-156. PubMed ID: 30272231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A case of systemic adverse effects after prolonged local therapy with betamethasone-17-valerate ointment].
    Halsos AM
    Tidsskr Nor Laegeforen; 1978 Feb; 98(4):199-200. PubMed ID: 625746
    [No Abstract]   [Full Text] [Related]  

  • 39. Fatal disseminated cytomegalovirus infection in an infant with Cushing's syndrome caused by topical steroid.
    Guven A; Karadeniz S; Aydin O; Akbalik M; Aydin M
    Horm Res; 2005; 64(1):35-8. PubMed ID: 16088205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cushing's syndrome and pituitary-adrenal suppression due to clobetasol propionate.
    Staughton RC; August PJ
    Br Med J; 1975 May; 2(5968):419-21. PubMed ID: 1125562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.